What is the appropriate management for adult hiccups, including non‑pharmacologic measures and pharmacologic therapy?

Management of Adult Hiccups

For persistent or intractable hiccups in adults, initiate treatment with baclofen (5-10 mg three times daily) or gabapentin (300-900 mg daily in divided doses) as first-line pharmacologic therapy, as these agents have the best evidence for efficacy with favorable safety profiles for long-term use. 1, 2

Initial Assessment and Non-Pharmacologic Measures

Before initiating pharmacologic therapy, identify and treat any underlying cause:

• Gastric overdistension/GERD: Most common identifiable cause. Consider empirical anti-reflux therapy with proton pump inhibitors (avoid omeprazole as it induces CYP1A2 and lowers drug levels) 3, 4
• Medication-induced: Review current medications, particularly dexamethasone and other steroids, chemotherapy agents (especially cisplatin), anti-parkinsonism drugs, and anesthetic agents 5, 4
• Neurologic causes: Stroke, space-occupying lesions, or injury affecting the hiccup reflex arc 6
• Cardiovascular/pulmonary: Myocardial ischemia, pericarditis, or thoracic pathology 4

Physical Maneuvers (for acute hiccups <48 hours)

These rarely require medical intervention but may include:

• Breath-holding techniques
• Valsalva maneuver
• Drinking cold water rapidly
• Swallowing granulated sugar
• Applying pressure to the diaphragm 4, 6

Pharmacologic Treatment Algorithm

First-Line Agents

Baclofen is supported by randomized controlled trial data:

• Start: 5 mg three times daily
• Titrate up to 10-20 mg three times daily as needed
• Mechanism: GABA-B agonist affecting the hiccup reflex arc
• Advantages: Lower side effect profile for long-term use compared to neuroleptics 1, 2

Gabapentin (alternative first-line):

• Start: 300 mg daily
• Titrate to 300-400 mg three times daily (maximum 900 mg/day)
• Mechanism: Modulates central nervous system pathways
• Advantages: Well-tolerated for chronic use 1, 2

Second-Line Agents

Metoclopramide (if GERD suspected or first-line fails):

• Dose: 10 mg four times daily
• Supported by randomized controlled trial data
• Mechanism: Prokinetic and dopamine antagonist
• Caution: Risk of extrapyramidal symptoms with prolonged use 1, 2

Chlorpromazine (FDA-approved but reserve for refractory cases):

• Dose: 25-50 mg orally or intramuscularly three to four times daily
• Only FDA-approved agent for hiccups 7, 2, 8
• Major caveat: Risk of QTc prolongation, hypotension, and extrapyramidal symptoms; requires cardiac monitoring 7
• More effective but higher side effect burden than baclofen/gabapentin 1, 8

Alternative Agents for Refractory Cases

Olanzapine:

• Dose: 2.5-10 mg orally
• Evidence from case series showing complete resolution 8
• Better side effect profile than typical antipsychotics

Haloperidol:

• Dose: 1-2 mg orally or intramuscularly
• Effective but carries risk of extrapyramidal symptoms 8

Special Populations

Cancer Patients on Chemotherapy

Steroid rotation is most effective:

• Replace dexamethasone with methylprednisolone OR omit dexamethasone entirely
• This intervention showed the highest success rate in cancer patients 5
• Baclofen remains effective as adjunctive therapy 5

Patients Unable to Take Oral Medications

• Chlorpromazine: 25-50 mg IM
• Haloperidol: 1-2 mg IM
• Consider subcutaneous routes if IV access unavailable 7

Critical Monitoring Requirements

When using antipsychotics (chlorpromazine, haloperidol):

• Baseline and periodic ECG monitoring for QTc prolongation
• Avoid in patients taking other QTc-prolonging medications (macrolides, fluoroquinolones, ondansetron, azithromycin) 7
• Monitor for orthostatic hypotension, especially with chlorpromazine
• Watch for dystonic reactions and extrapyramidal symptoms 7

Duration of Treatment

• Acute hiccups (<48 hours): Usually self-limited, rarely require treatment 4
• Persistent hiccups (48 hours to 2 months): Treat until resolution, typically days to weeks
• Intractable hiccups (>2 months): May require long-term therapy; baclofen and gabapentin preferred for chronic use due to safety profile 1

When to Refer

Consider specialty consultation when:

• Hiccups persist despite trial of baclofen/gabapentin AND second-line agents
• Underlying neurologic or structural cause suspected requiring intervention
• Surgical options (phrenic nerve blockade, vagal nerve stimulation) being considered for truly intractable cases 6

Key Clinical Pitfalls

• Do not delay treatment of persistent hiccups (>48 hours) as they significantly impair quality of life, sleep, and nutrition 4
• Avoid chlorpromazine as first-line despite FDA approval; baclofen and gabapentin have better risk-benefit profiles 1
• Always consider medication-induced causes, particularly steroids in cancer patients—simple steroid rotation may resolve the problem 5
• Do not use nebulized opioids—systematic reviews show no benefit over placebo for hiccups 9